The Impact of Pre-analytical Quality Initiatives on Cholangiocarcinoma Diagnostics in Thailand
Copyright © 2022 Koonmee, Sangkhamanon, Intarawichian, Aphivatanasiri, Kunprom, Sa-ngiamwibool, Balthaisong, Phuyao, Prajumwongs, Alaghehbandan and Thanee..
Cholangiocarcinoma (CCA) is the most prevalent malignancy in Thailand, with unfortunate late diagnosis and frequent metastatic disease outcomes. An accurate tissue diagnosis is the first and most important step in the treatment of CCA. Tissue quality and preservation during the pre-analytical phase play major roles in the proper histological evaluation and potential biomarker testing. This study evaluated the impact of using the "Cholangiocarcinoma Screening and Care Program (CASCAP)" container, as an innovative tool to address pre-analytical challenges faced by pathology laboratories in Thailand. This is a comparison study examining the quality of CCA specimens using the CASCAP container vs. the conventional method, using hematoxylin and eosin (H&E) and immunohistochemistry (IHC). CCA tissue quality using the CASCAP container significantly reduced artifact deposition while improving the cellular structure and nuclear and cytoplasmic morphologies. The immunohistochemical expression of cytokeratin 19 (CK19), a prognostic marker in CCA, significantly improved in the CASCAP container group in comparison with the conventional method. This innovation is proven to significantly enhance the CCA tissue quality diagnostics and prognostic biomarker testing, hence improving overall cancer care, diagnosis, and treatment in Thailand.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|---|
| Enthalten in: |
Frontiers in public health - 10(2022) vom: 20., Seite 792847 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Koonmee, Supinda [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cholangiocarcinoma |
|---|
| Anmerkungen: |
Date Completed 28.06.2022 Date Revised 16.07.2022 published: Electronic-eCollection Citation Status MEDLINE |
|---|
| doi: |
10.3389/fpubh.2022.792847 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM342786148 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM342786148 | ||
| 003 | DE-627 | ||
| 005 | 20231226014924.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3389/fpubh.2022.792847 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1142.xml |
| 035 | |a (DE-627)NLM342786148 | ||
| 035 | |a (NLM)35757604 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Koonmee, Supinda |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The Impact of Pre-analytical Quality Initiatives on Cholangiocarcinoma Diagnostics in Thailand |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.06.2022 | ||
| 500 | |a Date Revised 16.07.2022 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2022 Koonmee, Sangkhamanon, Intarawichian, Aphivatanasiri, Kunprom, Sa-ngiamwibool, Balthaisong, Phuyao, Prajumwongs, Alaghehbandan and Thanee. | ||
| 520 | |a Cholangiocarcinoma (CCA) is the most prevalent malignancy in Thailand, with unfortunate late diagnosis and frequent metastatic disease outcomes. An accurate tissue diagnosis is the first and most important step in the treatment of CCA. Tissue quality and preservation during the pre-analytical phase play major roles in the proper histological evaluation and potential biomarker testing. This study evaluated the impact of using the "Cholangiocarcinoma Screening and Care Program (CASCAP)" container, as an innovative tool to address pre-analytical challenges faced by pathology laboratories in Thailand. This is a comparison study examining the quality of CCA specimens using the CASCAP container vs. the conventional method, using hematoxylin and eosin (H&E) and immunohistochemistry (IHC). CCA tissue quality using the CASCAP container significantly reduced artifact deposition while improving the cellular structure and nuclear and cytoplasmic morphologies. The immunohistochemical expression of cytokeratin 19 (CK19), a prognostic marker in CCA, significantly improved in the CASCAP container group in comparison with the conventional method. This innovation is proven to significantly enhance the CCA tissue quality diagnostics and prognostic biomarker testing, hence improving overall cancer care, diagnosis, and treatment in Thailand | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a cholangiocarcinoma | |
| 650 | 4 | |a histopathology | |
| 650 | 4 | |a immunohistochemistry | |
| 650 | 4 | |a pre-analytical phase | |
| 650 | 4 | |a tissue preservation | |
| 700 | 1 | |a Sangkhamanon, Sakkarn |e verfasserin |4 aut | |
| 700 | 1 | |a Intarawichian, Piyapharom |e verfasserin |4 aut | |
| 700 | 1 | |a Aphivatanasiri, Chaiwat |e verfasserin |4 aut | |
| 700 | 1 | |a Kunprom, Waritta |e verfasserin |4 aut | |
| 700 | 1 | |a Sa-Ngiamwibool, Prakasit |e verfasserin |4 aut | |
| 700 | 1 | |a Balthaisong, Suwit |e verfasserin |4 aut | |
| 700 | 1 | |a Phuyao, Chitsakul |e verfasserin |4 aut | |
| 700 | 1 | |a Prajumwongs, Piya |e verfasserin |4 aut | |
| 700 | 1 | |a Alaghehbandan, Reza |e verfasserin |4 aut | |
| 700 | 1 | |a Thanee, Malinee |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Frontiers in public health |d 2013 |g 10(2022) vom: 20., Seite 792847 |w (DE-627)NLM23377548X |x 2296-2565 |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2022 |g day:20 |g pages:792847 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3389/fpubh.2022.792847 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 2022 |b 20 |h 792847 | ||